D'Hondt M, Lapointe R, Benamira Z, Pottel H, Plasse M, Letourneau R, et al. Carcinoma of the gallbladder: patterns of presentation, prognostic factors and survival rate. An 11-year single centre experience. Eur J Surg Oncol. 2013 Jun. 39 (6):548-53. [QxMD MEDLINE Link].
Blalock AA. A statistical study of 888 cases of biliary tract disease. Johns Hopkins Hospital Bulletin. 1924. 35:391-409.
Shirai Y, Yoshida K, Tsukada K, Ohtani T, Muto T. Identification of the regional lymphatic system of the gallbladder by vital staining. Br J Surg. 1992 Jul. 79 (7):659-62. [QxMD MEDLINE Link].
Davis JL, Kingham TP. Tumors of the gallbladder. Jarnagin WR, Allen PJ, Chapman WC, et al, eds. Blumgart's Surgery of the Liver, Biliary Tract, and Pancreas. 6th ed. Philadelphia: Elsevier; 2017. 786-804.
Kwon AH, Inui H, Matsui Y, Uchida Y, Hukui J, Kamiyama Y. Laparoscopic cholecystectomy in patients with porcelain gallbladder based on the preoperative ultrasound findings. Hepatogastroenterology. 2004 Jul-Aug. 51 (58):950-3. [QxMD MEDLINE Link].
Stephen AE, Berger DL. Carcinoma in the porcelain gallbladder: a relationship revisited. Surgery. 2001 Jun. 129 (6):699-703. [QxMD MEDLINE Link].
Chu H, Shi Y, Liu J, Huang D, Zhang J, Dou C. Update in clinical management for gallbladder neuroendocrine carcinoma. Medicine (Baltimore). 2021 Apr 9. 100 (14):e25449. [QxMD MEDLINE Link]. [Full Text].
Renehan AG, Tyson M, Egger M, Heller RF, Zwahlen M. Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies. Lancet. 2008 Feb 16. 371 (9612):569-78. [QxMD MEDLINE Link].
Cancer Facts and Figures 2021. American Cancer Society. Available at https://www.cancer.org/content/dam/cancer-org/research/cancer-facts-and-statistics/annual-cancer-facts-and-figures/2021/cancer-facts-and-figures-2021.pdf. 2021; Accessed: April 23, 2021.
Howlader N, Noone AM, Krapcho M, Miller D, Brest A, Yu M, et al. SEER Cancer Statistics Review (CSR) 1975-2018. National Cancer Institute. Available at https://seer.cancer.gov/csr/1975_2018/. April 15, 2021; Accessed: April 23, 2021.
Shindoh J, de Aretxabala X, Aloia TA, Roa JC, Roa I, Zimmitti G, et al. Tumor location is a strong predictor of tumor progression and survival in T2 gallbladder cancer: an international multicenter study. Ann Surg. 2015 Apr. 261 (4):733-9. [QxMD MEDLINE Link].
Okada K, Kijima H, Imaizumi T, Hirabayashi K, Matsuyama M, Yazawa N, et al. Wall-invasion pattern correlates with survival of patients with gallbladder adenocarcinoma. Anticancer Res. 2009 Feb. 29 (2):685-91. [QxMD MEDLINE Link].
Li H, Yuan SL, Han ZZ, Huang J, Cui L, Jiang CQ, et al. Prognostic significance of the tumor-stroma ratio in gallbladder cancer. Neoplasma. 2017. 64 (4):588-593. [QxMD MEDLINE Link]. [Full Text].
Kim M, Kim H, Han Y, Sohn H, Kang JS, Kwon W, et al. Prognostic Value of Carcinoembryonic Antigen (CEA) and Carbohydrate Antigen 19-9 (CA 19-9) in Gallbladder Cancer; 65 IU/mL of CA 19-9 Is the New Cut-Off Value for Prognosis. Cancers (Basel). 2021 Mar 4. 13 (5):[QxMD MEDLINE Link]. [Full Text].
Kong W, Zhang L, An R, Yang M, Wang H. Diagnostic Value of Serum D-Dimer for Detection of Gallbladder Carcinoma. Cancer Manag Res. 2021. 13:2549-2556. [QxMD MEDLINE Link]. [Full Text].
Okuyama Y, Fukui A, Enoki Y, Morishita H, Yoshida N, Fujimoto S. A large cell neuroendocrine carcinoma of the gall bladder: diagnosis with 18FDG-PET/CT-guided biliary cytology and treatment with combined chemotherapy achieved a long-term stable condition. Jpn J Clin Oncol. 2013 May. 43 (5):571-4. [QxMD MEDLINE Link].
Dehdashti F, Laforest R, Gao F, Shoghi KI, Aft RL, Nussenbaum B, et al. Assessment of cellular proliferation in tumors by PET using 18F-ISO-1. J Nucl Med. 2013 Mar. 54 (3):350-7. [QxMD MEDLINE Link].
Chun YJ, Jeung HC, Park HS, Park JS, Rha SY, Choi HJ, et al. Significance of Metabolic Tumor Volume and Total Lesion Glycolysis Measured Using ¹⁸F-FDG PET/CT in Locally Advanced and Metastatic Gallbladder Carcinoma. Yonsei Med J. 2019 Jul. 60 (7):604-610. [QxMD MEDLINE Link]. [Full Text].
Gallbladder cancer treatment (PDQ®)–health professional version. National Cancer Institute. Available at https://www.cancer.gov/types/gallbladder/hp/gallbladder-treatment-pdq#section/_6. January 27, 2021; Accessed: April 23, 2021.
Zielinski MD, Atwell TD, Davis PW, Kendrick ML, Que FG. Comparison of surgically resected polypoid lesions of the gallbladder to their pre-operative ultrasound characteristics. J Gastrointest Surg. 2009 Jan. 13 (1):19-25. [QxMD MEDLINE Link].
Matsuyama R, Yabusita Y, Homma Y, Kumamoto T, Endo I. Essential updates 2019/2020: Surgical treatment of gallbladder cancer. Ann Gastroenterol Surg. 2021 Mar. 5 (2):152-161. [QxMD MEDLINE Link]. [Full Text].
Park JO, Oh DY, Hsu C, Chen JS, Chen LT, Orlando M, et al. Gemcitabine Plus Cisplatin for Advanced Biliary Tract Cancer: A Systematic Review. Cancer Res Treat. 2015 Jul. 47 (3):343-61. [QxMD MEDLINE Link].
Duffy A, Capanu M, Abou-Alfa GK, Huitzil D, Jarnagin W, Fong Y, et al. Gallbladder cancer (GBC): 10-year experience at Memorial Sloan-Kettering Cancer Centre (MSKCC). J Surg Oncol. 2008 Dec 1. 98 (7):485-9. [QxMD MEDLINE Link].
[Guideline] Hepatobiliary cancers. Version 2.2021. NCCN Clinical Practice Guidelines in Oncology™. Available at https://www.nccn.org/professionals/physician_gls/pdf/hepatobiliary.pdf. April 16, 2021; Accessed: April 23, 2021.
Mitin T, Enestvedt CK, Jemal A, Sineshaw HM. Limited Use of Adjuvant Therapy in Patients With Resected Gallbladder Cancer Despite a Strong Association With Survival. J Natl Cancer Inst. 2017 Jul 1. 109 (7):[QxMD MEDLINE Link].
[Guideline] Shroff RT, Kennedy EB, Bachini M, Bekaii-Saab T, Crane C, Edeline J, et al. Adjuvant Therapy for Resected Biliary Tract Cancer: ASCO Clinical Practice Guideline. J Clin Oncol. 2019 Apr 20. 37 (12):1015-1027. [QxMD MEDLINE Link]. [Full Text].
Reddy SK, Clary BM. Surgical management of gallbladder cancer. Surg Oncol Clin N Am. 2009 Apr. 18 (2):307-24, ix. [QxMD MEDLINE Link].
[Guideline] Wiles R, Thoeni RF, Barbu ST, Vashist YK, Rafaelsen SR, Dewhurst C, et al. Management and follow-up of gallbladder polyps : Joint guidelines between the European Society of Gastrointestinal and Abdominal Radiology (ESGAR), European Association for Endoscopic Surgery and other Interventional Techniques (EAES), International Society of Digestive Surgery - European Federation (EFISDS) and European Society of Gastrointestinal Endoscopy (ESGE). Eur Radiol. 2017 Sep. 27 (9):3856-3866. [QxMD MEDLINE Link]. [Full Text].
Wang Z, Li Y, Jiang W, Yan J, Dai J, Jiao B, et al. Simple Cholecystectomy Is Adequate for Patients With T1b Gallbladder Adenocarcinoma < 1 cm in Diameter. Front Oncol. 2019. 9:409. [QxMD MEDLINE Link]. [Full Text].
He XD, Li JJ, Liu W, Qu Q, Hong T, Xu XQ, et al. Surgical procedure determination based on tumor-node-metastasis staging of gallbladder cancer. World J Gastroenterol. 2015 Apr 21. 21 (15):4620-6. [QxMD MEDLINE Link].
Ito H, Ito K, D'Angelica M, Gonen M, Klimstra D, Allen P, et al. Accurate staging for gallbladder cancer: implications for surgical therapy and pathological assessment. Ann Surg. 2011 Aug. 254 (2):320-5. [QxMD MEDLINE Link].
Tsilimigras DI, Hyer JM, Paredes AZ, Moris D, Beal EW, Merath K, et al. The optimal number of lymph nodes to evaluate among patients undergoing surgery for gallbladder cancer: Correlating the number of nodes removed with survival in 6531 patients. J Surg Oncol. 2019 Jun. 119 (8):1099-1107. [QxMD MEDLINE Link].